News & Updates

Show Multimedia Only

Stroke one of the strongest predictors of COVID-19 mortality

06 Jan 2022 by

A territory-wide retrospective cohort study by the Chinese University of Hong Kong (CUHK) has found that stroke is the third strongest predictor of coronavirus disease 2019 (COVID-19) mortality, after advancing age and renal disease, while Parkinson’s disease (PD) was the second strongest predictor of death after advancing age during the severe acute respiratory syndrome (SARS) epidemic of 2003.

Stroke one of the strongest predictors of COVID-19 mortality

06 Jan 2022

COVID-19 vaccines promising in multiple myeloma patients

05 Jan 2022

Vaccination against SARS-CoV-2 appears to lead to favourable outcomes in multiple myeloma (MM) patients who contract the coronavirus disease 2019 (COVID-19), even in the presence of negative prognostic factors, a recent study has found.

COVID-19 vaccines promising in multiple myeloma patients

05 Jan 2022

No reduction in COVID-19 hospitalization, death with icosapent ethyl

04 Jan 2022 by

Treatment with icosapent ethyl did not reduce the rate of hospitalization or mortality among patients with SARS-CoV-2 infection, according to results of the PREPARE IT-2* trial presented at AHA 2021.

No reduction in COVID-19 hospitalization, death with icosapent ethyl

04 Jan 2022

Lower risk of SARS-CoV-2 after booster dose

03 Jan 2022 by

Receipt of a booster dose of the BNT162b2 mRNA vaccine is tied to a reduced risk of testing positive for SARS-CoV-2, according to results of a study from Israel.

Lower risk of SARS-CoV-2 after booster dose

03 Jan 2022

COVID-19 vax in kids: Which group to target first?

30 Dec 2021 by

Children with asthma who are infected with SARS-CoV-2 virus are at an increased risk of hospitalization, especially those whose asthma is poorly controlled, compared with children without asthma, according to data from the EAVE II* study.

COVID-19 vax in kids: Which group to target first?

30 Dec 2021

Omicron raises new fears

28 Dec 2021 by

The threat of Omicron is real, with scientists working at breakneck speed to better understand its virulence and potential ability to evade currently approved vaccines.

Omicron raises new fears

28 Dec 2021

Vulnerable patients may need more help in the COVID-19 pandemic era

28 Dec 2021 by

With the situation of the COVID-19 pandemic, it is clear that the SARS-CoV-2 virus will be with us for a long time. A media roundtable organized by Roche Malaysia recently discussed the various ways in which vulnerable patient populations can cope with living in a world where vaccinations alone may not be sufficient.

Vulnerable patients may need more help in the COVID-19 pandemic era

28 Dec 2021

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

27 Dec 2021 by

A large retrospective study conducted in the US and Europe and presented at RSNA 2021 has suggested that central nervous system (CNS) complications may affect approximately one in 100 patients hospitalized with COVID-19.

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

27 Dec 2021

How well do booster shots protect against Omicron?

26 Dec 2021 by

With the latest surge of COVID-19 cases sweeping across the world, countries have been stepping up on their booster vaccination programme to curb the spread of COVID-19.

How well do booster shots protect against Omicron?

26 Dec 2021

STEMI hospitalizations down during pandemic

26 Dec 2021

There was a significant drop in hospitalizations for ST-segment elevation myocardial infarction (STEMI) during the coronavirus disease 2019 (COVID-19) pandemic, a recent study has found.

STEMI hospitalizations down during pandemic

26 Dec 2021

News & Updates

Showing Infectious Diseases articles

Showing

Specialty:

Stroke one of the strongest predictors of COVID-19 mortality

Stroke one of the strongest predictors of COVID-19 mortality

COVID-19 vaccines promising in multiple myeloma patients

COVID-19 vaccines promising in multiple myeloma patients

No reduction in COVID-19 hospitalization, death with icosapent ethyl

No reduction in COVID-19 hospitalization, death with icosapent ethyl

Lower risk of SARS-CoV-2 after booster dose

Lower risk of SARS-CoV-2 after booster dose

COVID-19 vax in kids: Which group to target first?

COVID-19 vax in kids: Which group to target first?

Omicron raises new fears

Omicron raises new fears

Vulnerable patients may need more help in the COVID-19 pandemic era

Vulnerable patients may need more help in the COVID-19 pandemic era

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

CNS complications in COVID-19: 1 in 100 hospitalized patients affected

How well do booster shots protect against Omicron?

How well do booster shots protect against Omicron?

STEMI hospitalizations down during pandemic

STEMI hospitalizations down during pandemic